For research use only. Not for therapeutic Use.
Vadastuximab is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine[1].
| Catalog Number | I042249 |
| CAS Number | 1436390-64-5 |
| Purity | ≥95% |
| Reference | [1]. Eytan M Stein, et al. A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia. Blood. 2018 Jan 25;131(4):387-396. |
